Skip to content

Sana Biotechnology SANA Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Precigen logo
PrecigenPGEN
Artivion logo
ArtivionAORT
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$912.8M+54.1%
Enterprise value$904.32M+53.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's accrued manufacturing costs?
Sana Biotechnology (SANA) reported accrued manufacturing costs of $7.58M in Q1 2026.
How has Sana Biotechnology's accrued manufacturing costs changed year-over-year?
Sana Biotechnology's accrued manufacturing costs decreased by 18.9% year-over-year, from $9.35M to $7.58M.
What is the long-term trend for Sana Biotechnology's accrued manufacturing costs?
Over 5 years (2020 to 2025), Sana Biotechnology's accrued manufacturing costs has grown at a -3.7% compound annual growth rate (CAGR), from $16.02M to $13.24M.